Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

589
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
589
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

4.0K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
4.0K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

2.2K
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
2.2K
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

1.8K
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.8K
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

20
A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
20
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

30
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
30
  1. 首页
  3. 患有新发性心房动的血液透析患者的死亡和中风风险:全国性队列的竞争风险分析
  1. 首页
  3. 患有新发性心房动的血液透析患者的死亡和中风风险:全国性队列的竞争风险分析

相关实验视频

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.7K

患有新发性心房动的血液透析患者的死亡和中风风险:全国性队列的竞争风险分析

Chia-Jen Shih1, Shuo-Ming Ou1, Pei-Wen Chao1

  • 1From School of Medicine, National Yang-Ming University, Taipei, Taiwan (C.-J.S., S.-M.O., S.-C.K., Y.-J.L., C.-Y.Y., D.-C.T., C.-C.L., P.-H.H., S.-Y.L., Y.-T.C.); Department of Medicine, Taipei Veterans General Hospital, Yuanshan Branch, Yilan, Taiwan (C.-J.S.); Deran Clinic, Yilan, Taiwan (C.-J.S.); Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan (S.-M.O., C.-Y.Y., D.-C.T., C.-C.L., S.-Y.L.); Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan (S.-M.O., Y.-T.C.); Department of Anesthesiology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan (P.-W.C.); School of Medicine, Taipei Medical University, Taipei, Taiwan (P.-W.C.); National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli County, Taiwan (S.-C.K.); Division of Infectious Diseases, Taipei Veterans General Hospital, Taipei, Taiwan (S.-C.K.); Department of Neurology, Taipei City Hospital, Ren Ai Branch, Taipei, Taiwan (Y.-J.L.); Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan (P.-H.H.); and Division of Nephrology, Department of Medicine, Taipei City Hospital, Heping Fuyou Branch, Taipei, Taiwan (Y.-T.C.).

Circulation
|December 19, 2015

在PubMed 上查看摘要

概括
此摘要是机器生成的。

患有新发性心房动的血液透析患者的中风风险略有增加,但在考虑住院死亡时,这种风险变得微不足道. 这一发现影响了该群体使用抗凝剂的考虑.

关键词:
心房动死亡透析流行病学没有风险一次中风

更多相关视频

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.3K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

772

相关实验视频

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.7K
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.3K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

772

科学领域:

  • 肝脏病学
  • 心脏病学
  • 流行病学

背景情况:

  • 由于风险与益处不清楚,在血液透析患者中使用口服抗凝剂存在争议.
  • 对于抗凝剂在高危人群中的净益处存在不确定性.

研究的目的:

  • 与没有心律失常的患者相比,研究血液透析患者新发性肌痛风暴的缺血性中风风险
  • 在接受血液透析的患者中评估心血管事件风险.

主要方法:

  • 全国范围,以人口为基础,倾向性得分匹配的队列研究.
  • 使用台湾国家健康保险研究数据库 (1998-2011).
  • 包括接受血液透析的非膜肌痛新发患者和没有心律失常的匹配对照.

主要成果:

  • 患有AF的患者 (n=6772) 患有缺血性中风 (aHR,1. 27),因任何原因死亡 (aHR,1. 59) 和心力衰竭住院 (aHR,1. 90) 的风险较高.
  • 当在医院死亡被认为是竞争风险时,AF显著增加心力衰竭风险 (HR,1. 56),而不是缺血性中风或心肌梗塞.
  • 在竞争风险模型中,缺血性中风的CHA2DS2- VASc得分的预测值有所降低.

结论:

  • 血液透析患者的中风风险与没有中风的患者相比仅略有增加.
  • 这种增加的中风风险在医院死亡的竞争风险中变得无关紧要.
  • 这些发现表明,在这个特定的患者群体中重新评估抗凝剂治疗的益处.